Small-cap growth stocks often play second fiddle to their larger counterparts in today's market. Over the past two years, investors have flocked toward a small handful of well-known large-cap equities in the fields of artificial intelligence (AI) and weight loss drugs.

The attraction lies in the anticipation that both AI and weight loss drugs will drive substantial revenue growth for industry behemoths in the forthcoming years. While these prospects are likely to materialize, several small-cap growth stocks still have the potential to outperform even the leading entities in AI and weight loss care.

Image Source: Getty Images.

Continue reading

Source Fool.com